Solitaire group (n=13) | Penumbra group (n=18) | p Value | |
---|---|---|---|
Age | 68.9±10.4 | 66.4±11.4 | 0.543 |
Male (n (%)) | 7 (53.8) | 14 (77.8) | 0.247 |
Presentation time (min) | 231.2±191.5 | 127.2±94.2 | 0.089 |
Initial NIHSS | 27.3±11.0 | 21.3±9.7 | 0.120 |
Hypertension (n (%)) | 7 (53.8) | 8 (44.4) | 0.722 |
Diabetes mellitus (n (%)) | 2 (15.4) | 10 (55.6) | 0.032* |
Smoker (n (%)) | 3 (23.1) | 12 (66.7) | 0.029* |
Alcohol user ((n (%)) | 3 (23.1) | 12 (66.7) | 0.029* |
A Fib (n (%)) | 6 (46.2) | 8 (44.4) | 1.000 |
Dyslipidemia (n (%)) | 1 (7.7) | 18 (100) | 0.000* |
Total cholesterol (mg/dL) | 191.5±55.5 | 155.1±26.8 | 0.044* |
Prior stroke (n (%)) | 3 (23.1) | 15 (83.3) | 0.001* |
Cardiogenic embolism (n (%)) | 9 (69.2) | 10 (55.6) | 0.579 |
IV thrombolysis (n (%)) | 5 (38.5) | 9 (50) | 0.717 |
Time to treatment (min) | 117.4±57.0 | 109.2±65.4 | 0.720 |
Procedure time (min) | 101.9±41.4 | 62.3±34.8 | 0.044* |
Successful recanalization | 11 (84.6) | 18 (100) | 0.168 |
Complete recanalization | 3 (23.1) | 13 (72.2) | 0.015* |
NIHSS on discharge | 17.6±15.4 | 16.4±14.0 | 0.827 |
mRS on discharge | 3.5±2.2 | 3.7±1.8 | 0.779 |
mRS at 3 months | 3.6±2.6 | 3.3±2.6 | 0.726 |
Good outcome at 3 months | 5 (38.5) | 8 (44.4) | 1.000 |
Poor outcome at 3 months | 7 (53.8) | 8 (44.4) | 0.722 |
*p<0.05.
Presentation time=time interval from stroke symptom onset to hospital presentation.
Procedure time=time interval from commencement to the end of the procedure.
Successful recanalization=final TICI score of 2b or 3.
Complete recanalization=final TICI score of 3.
Good outcome at 3 months=patients with mRS scores of 0, 1, and 2, 3 months after their procedures.
Poor outcome at 3 months=patients with mRS scores of 5 and 6, 3 months after their procedure.
A Fib, atrial fibrillation; IV thrombolysis, intravenous thrombolytic therapy using recombinant tissue plasminogen activator; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; TICI, Thrombolysis in Cerebral Infarction.